Home/Filings/4/0001179110-16-024208
4//SEC Filing

RIGEL PHARMACEUTICALS INC 4

Accession 0001179110-16-024208

$RIGLCIK 0001034842operating

Filed

May 8, 8:00 PM ET

Accepted

May 9, 6:38 PM ET

Size

5.2 KB

Accession

0001179110-16-024208

Insider Transaction Report

Form 4
Period: 2016-05-05
Duliege Anne-Marie
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-05-05+400,000400,000 total
    Exercise: $2.54Exp: 2026-05-05Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]One fourth (1/4th) of the option vests one year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.

Issuer

RIGEL PHARMACEUTICALS INC

CIK 0001034842

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001034842

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 6:38 PM ET
Size
5.2 KB